Phil Lake

1.5k total citations
38 papers, 1.3k citations indexed

About

Phil Lake is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Phil Lake has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Immunology, 16 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Molecular Biology. Recurrent topics in Phil Lake's work include Monoclonal and Polyclonal Antibodies Research (16 papers), T-cell and B-cell Immunology (16 papers) and Immune Cell Function and Interaction (12 papers). Phil Lake is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (16 papers), T-cell and B-cell Immunology (16 papers) and Immune Cell Function and Interaction (12 papers). Phil Lake collaborates with scholars based in United States, United Kingdom and Japan. Phil Lake's co-authors include James N. Woody, Jonathan R. Lamb, David D. Eckels, N Mitchison, Edward A. Clark, Robert J. Hartzman, Geoffrey H. Sunshine, Nicola Green, Mark Brunswick and Armead H. Johnson and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Phil Lake

36 papers receiving 1.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Phil Lake 888 450 303 243 134 38 1.3k
A. Miller 895 1.0× 314 0.7× 364 1.2× 138 0.6× 117 0.9× 25 1.3k
D B Wilde 1.3k 1.5× 603 1.3× 258 0.9× 151 0.6× 106 0.8× 10 1.6k
Bruce Babbitt 984 1.1× 447 1.0× 437 1.4× 133 0.5× 147 1.1× 11 1.3k
G J Hämmerling 1.2k 1.3× 643 1.4× 523 1.7× 218 0.9× 99 0.7× 28 1.7k
Zou Quan 936 1.1× 330 0.7× 195 0.6× 131 0.5× 139 1.0× 2 1.2k
M E Dorf 1.2k 1.3× 329 0.7× 293 1.0× 160 0.7× 94 0.7× 71 1.5k
J. A. Frelinger 658 0.7× 228 0.5× 310 1.0× 241 1.0× 133 1.0× 47 1.1k
Ronald B. Corley 1.3k 1.5× 447 1.0× 524 1.7× 117 0.5× 158 1.2× 83 1.9k
W Roeder 966 1.1× 613 1.4× 829 2.7× 103 0.4× 198 1.5× 14 1.8k
S Cooper 966 1.1× 214 0.5× 163 0.5× 96 0.4× 123 0.9× 8 1.2k

Countries citing papers authored by Phil Lake

Since Specialization
Citations

This map shows the geographic impact of Phil Lake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phil Lake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phil Lake more than expected).

Fields of papers citing papers by Phil Lake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phil Lake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phil Lake. The network helps show where Phil Lake may publish in the future.

Co-authorship network of co-authors of Phil Lake

This figure shows the co-authorship network connecting the top 25 collaborators of Phil Lake. A scholar is included among the top collaborators of Phil Lake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phil Lake. Phil Lake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wright, Richard M., et al.. (2001). A high-capacity alkaline phosphatase reporter system for the rapid analysis of specificity and relative affinity of peptides from phage-display libraries. Journal of Immunological Methods. 253(1-2). 223–232. 9 indexed citations
2.
Fu, Fen, et al.. (2001). FTY720, a novel immunosuppressive agent with insulinotropic activity, prolongs graft survival in a mouse islet transplantation model. Transplantation Proceedings. 33(1-2). 672–673. 17 indexed citations
3.
Hexham, J. Mark, Ron Hugo, Carol E. Dowling, et al.. (2001). Influence of relative binding affinity on efficacy in a panel of anti-CD3 scFv immunotoxins. Molecular Immunology. 38(5). 397–408. 28 indexed citations
4.
Hexham, J. Mark, Patrick Graff, Yan Wang, et al.. (2001). Optimization of the anti‐(human CD3) immunotoxin DT389–scFv(UCHT1) N‐terminal sequence to yield a homogeneous protein. Biotechnology and Applied Biochemistry. 34(3). 183–187. 1 indexed citations
5.
Lögdberg, Lennart, et al.. (1997). Delayed therapy with a polymyxin B-dextran conjugate (PMX-622) improves survival in rabbits with Gram-negative peritonitis. Journal of Endotoxin Research. 4(4). 285–292. 3 indexed citations
6.
Wright, Richard M., et al.. (1995). Binding Epitope of Somatostatin Defined by Phage-Displayed Peptide Libraries. Nature Biotechnology. 13(2). 165–169. 17 indexed citations
7.
Lögdberg, Lennart, et al.. (1994). Primate antibodies to components of the human immune system. Journal of Medical Primatology. 23(5). 285–297. 11 indexed citations
8.
Simpson, Lance L., Phil Lake, & S Kozaki. (1990). Isolation and characterization of a novel human monoclonal antibody that neutralizes tetanus toxin.. Journal of Pharmacology and Experimental Therapeutics. 254(1). 98–103. 14 indexed citations
9.
Lake, Phil, Edward A. Clark, Ichiro Nakashima, et al.. (1989). The regulation of antibody responses to antigens of the cell surface: studies with Thy-1 and H-2 antigens.. PubMed. 45. 367–94. 2 indexed citations
10.
Cowsert, Lex M., Phil Lake, & A. Bennett Jenson. (1987). Topographical and Conformational Epitopes of Bovine Papillomavirus Type 1 Defined by Monoclonal Antibodies<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 79(5). 1053–7. 41 indexed citations
11.
Lake, Phil & Mark Brunswick. (1986). T-Cell Replacing Factor Activity of Recombinant-Derived Interleukin-2 Requires Gamma-Interferon. Journal of Interferon Research. 6(3). 215–223. 2 indexed citations
12.
Brunswick, Mark & Phil Lake. (1986). Functional interactions of human and murine lymphoid cells. Cellular Immunology. 103(2). 441–454. 9 indexed citations
13.
Brunswick, Mark & Phil Lake. (1985). Obligatory role of gamma interferon in T cell-replacing factor-dependent, antigen-specific murine B cell responses.. The Journal of Experimental Medicine. 161(5). 953–971. 34 indexed citations
14.
Eckels, David D., Phil Lake, Jonathan R. Lamb, et al.. (1983). SB-restricted presentation of influenza and herpes simplex virus antigens to human T-Iymphocyte clones. Nature. 301(5902). 716–718. 140 indexed citations
15.
Bromberg, Jonathan S., Phil Lake, & Mark Brunswick. (1982). Viral antigens act as helper determinants for antibody responses to cell surface antigens.. The Journal of Immunology. 129(2). 683–688. 18 indexed citations
16.
Clark, Edward A., et al.. (1981). Modulation of Thy-1 alloantibody responses: donor cell-associated H-2 inhibition and augmentation without recipient Ir gene control.. The Journal of Immunology. 127(5). 2135–2140. 9 indexed citations
17.
Lake, Phil, et al.. (1979). Production and characterization of cytotoxic Thy‐1 antibody‐secreting hybrid cell lines Detection of T cell subsets. European Journal of Immunology. 9(11). 875–886. 172 indexed citations
18.
Lake, Phil & Tommy C. Douglas. (1978). Recognition and genetic control of helper determinants for cell surface antigen Thy–1. Nature. 275(5677). 220–222. 38 indexed citations
19.
Lake, Phil. (1976). Antibody response induced in vitro to the cell-surface alloantigen Thy–1. Nature. 262(5566). 297–298. 15 indexed citations
20.
Lake, Phil, et al.. (1971). A sensitive assay for transplantation immunity in mice.. PubMed. 3(1). 856–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026